InvestorsHub Logo
Followers 0
Posts 340
Boards Moderated 0
Alias Born 06/05/2019

Re: None

Monday, 12/02/2019 8:25:49 AM

Monday, December 02, 2019 8:25:49 AM

Post# of 7413
Revance Therapeutics announced the promotion of Dustin Sjuts to the role of Chief Commercial Officer, Aesthetics & Therapeutics, reporting directly to Mark Foley, Revance's President and CEO. In his new role, Sjuts will be responsible for all of the company's commercial operations and launch activities in preparation for DAXI's anticipated approval in the second half of 2020

Read more at:
https://thefly.com/landingPageNews.php?id=3000604
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News